109 related articles for article (PubMed ID: 7132919)
21. Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
Gemma S; Campiani G; Butini S; Joshi BP; Kukreja G; Coccone SS; Bernetti M; Persico M; Nacci V; Fiorini I; Novellino E; Taramelli D; Basilico N; Parapini S; Yardley V; Croft S; Keller-Maerki S; Rottmann M; Brun R; Coletta M; Marini S; Guiso G; Caccia S; Fattorusso C
J Med Chem; 2009 Jan; 52(2):502-13. PubMed ID: 19113955
[TBL] [Abstract][Full Text] [Related]
22. Retinal toxicity of chloroquine hydrochloride administered by intraperitoneal injection.
Gaynes BI; Torczynski E; Varro Z; Grostern R; Perlman J
J Appl Toxicol; 2008 Oct; 28(7):895-900. PubMed ID: 18484088
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence.
Nakazawa S
Exp Parasitol; 2005 Sep; 111(1):59-63. PubMed ID: 15961077
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
Solomon VR; Puri SK; Srivastava K; Katti SB
Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
[TBL] [Abstract][Full Text] [Related]
25. A study of the mechanisms of chloroquine retinopathy. I. Chloroquine effect on lipid peroxidation of retina.
Ivanina TA; Sakina NL; Lebedeva MN; Borovyagin VL
Ophthalmic Res; 1989; 21(3):216-20. PubMed ID: 2779975
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
[TBL] [Abstract][Full Text] [Related]
27. Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues.
Cunico W; Cechinel CA; Bonacorso HG; Martins MA; Zanatta N; de Souza MV; Freitas IO; Soares RP; Krettli AU
Bioorg Med Chem Lett; 2006 Feb; 16(3):649-53. PubMed ID: 16257205
[TBL] [Abstract][Full Text] [Related]
28. Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum.
Molyneaux CA; Krugliak M; Ginsburg H; Chibale K
Biochem Pharmacol; 2005 Dec; 71(1-2):61-8. PubMed ID: 16298348
[TBL] [Abstract][Full Text] [Related]
29. Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.
Bray PG; Deed S; Fox E; Kalkanidis M; Mungthin M; Deady LW; Tilley L
Biochem Pharmacol; 2005 Oct; 70(8):1158-66. PubMed ID: 16139253
[TBL] [Abstract][Full Text] [Related]
30. Differences in the retinotoxic action of chloroquine and phenothiazine derivatives.
Gregory MH; Rutty DA; Wood RD
J Pathol; 1970 Nov; 102(3):139-50. PubMed ID: 5508910
[No Abstract] [Full Text] [Related]
31. The in vivo sensitivity of Plasmodium falciparum to chloroquine in the Red River basin, Yunnan, China.
Hong-Ping G; Yao Z; Qian D; Jin-Hua Y; Kai-Xun J; Min Z
Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):692-5. PubMed ID: 10772547
[TBL] [Abstract][Full Text] [Related]
32. Control of heme polymerase by chloroquine and other quinoline derivatives.
Chou AC; Fitch CD
Biochem Biophys Res Commun; 1993 Aug; 195(1):422-7. PubMed ID: 8363618
[TBL] [Abstract][Full Text] [Related]
33. The antimalarial drug chloroquine inhibits glycerol uptake into cardiac cells.
Hatch GM; Ross TK
Proc West Pharmacol Soc; 1998; 41():21-4. PubMed ID: 9836229
[No Abstract] [Full Text] [Related]
34. Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling.
Gemma S; Kukreja G; Campiani G; Butini S; Bernetti M; Joshi BP; Savini L; Basilico N; Taramelli D; Yardley V; Bertamino A; Novellino E; Persico M; Catalanotti B; Fattorusso C
Bioorg Med Chem Lett; 2007 Jul; 17(13):3535-9. PubMed ID: 17493808
[TBL] [Abstract][Full Text] [Related]
35. Chloroquine therapy reduces oestrogen production in females.
Nicola WG
Boll Chim Farm; 1997 May; 136(5):447-9. PubMed ID: 9281894
[TBL] [Abstract][Full Text] [Related]
36. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
37. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function by chloroquine and related compounds in vitro and intoxification in vivo.
Bachmeyer C; Benz R; Barth H; Aktories K; Gilbert M; Popoff MR
FASEB J; 2001 Jul; 15(9):1658-60. PubMed ID: 11427518
[No Abstract] [Full Text] [Related]
38. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
[TBL] [Abstract][Full Text] [Related]
39. In vitro schizontocidal activity of standard antimalarial drugs on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum.
Sharma P; Pillai CR; Devi Sharma J
Indian J Exp Biol; 2000 Nov; 38(11):1129-33. PubMed ID: 11395957
[TBL] [Abstract][Full Text] [Related]
40. [Interaction of drugs and retinal cells].
Rosner J; Legros J
Actual Pharmacol (Paris); 1974; 27():87-115. PubMed ID: 4620130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
